A recent comprehensive review (Verdeccia et al. 2020) makes a compelling argument that this loss of ACE2 is a proximate cause of lung inflammatory cell infiltration and ARDS and that conditions in which ACE2 is already reduced (including aging) may exacerbate the severity of COVID-19. This evidence concerns the gene ACE2 and acute respiratory distress syndrome.